Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.

Campanati A, Martina E, Giuliodori K, Bobyr I, Consales V, Offidani A.

Dermatol Ther. 2019 Jan 28:e12841. doi: 10.1111/dth.12841. [Epub ahead of print]

PMID:
30693648
2.

Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.

Bobyr I, Campanati A, Giacchetti A, Offidani A.

Photodermatol Photoimmunol Photomed. 2019 Jan 28. doi: 10.1111/phpp.12452. [Epub ahead of print] No abstract available.

PMID:
30690758
3.

Relapsing acute generalized exanthematous pustolosis: a guess.

Consales V, Campanati A, Bobyr I, Molinelli E, Brisigotti V, Giuliodori K, Ganzetti G, Giangiacomi M, Offidani A.

G Ital Dermatol Venereol. 2019 Feb;154(1):82-83. doi: 10.23736/S0392-0488.16.05292-5. No abstract available.

PMID:
30616333
4.

"SENECA" Sinecatechins 10% ointment: A green tea extract for the treatment of actinic keratosis. Case series.

Bobyr I, Campanati A, Offidani A.

Dermatol Ther. 2018 Sep;31(5):e12634. doi: 10.1111/dth.12634. Epub 2018 Sep 2. No abstract available.

PMID:
30175472
5.

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Campanati A, Consales V, Orciani M, Giuliodori K, Ganzetti G, Bobyr I, Sorgentoni G, di Primio R, Offidani A.

Psoriasis (Auckl). 2017 Nov 27;7:73-85. doi: 10.2147/PTT.S108311. eCollection 2017. Review.

6.

Botulinum Toxin Off-Label Use in Dermatology: A Review.

Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A.

Skin Appendage Disord. 2017 Mar;3(1):39-56. doi: 10.1159/000452341. Epub 2017 Feb 1. Review.

7.

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, Di Ruscio G, Bobyr I, Emanuelli M, Offidani A.

J Int Med Res. 2016 Sep;44(1 suppl):10-14.

8.

Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study.

Bobyr I, Campanati A, Consales V, Martina E, Molinelli E, Diotallevi F, Brisigotti V, Giangiacomi M, Ganzetti G, Giuliodori K, Offidani A.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):260-266. doi: 10.1111/jdv.13831. Epub 2016 Jul 25.

PMID:
27453064
9.

Granuloma faciale successfully treated with ingenol mebutate.

Bobyr I, Campanati A, Consales V, Giangiacomi M, Diotallevi F, Offidani A.

Dermatol Ther. 2016 Sep;29(5):325-329. doi: 10.1111/dth.12368. Epub 2016 Jun 30.

PMID:
27364361
10.

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series.

Bobyr I, Campanati A, Consales V, Giuliodori K, Scalise A, Offidani A.

Springerplus. 2016 May 14;5:627. doi: 10.1186/s40064-016-2290-6. eCollection 2016.

11.

Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment.

Marconi B, Bobyr I, Campanati A, Molinelli E, Consales V, Brisigotti V, Scarpelli M, Racchini S, Offidani A.

Intractable Rare Dis Res. 2015 Aug;4(3):113-22. doi: 10.5582/irdr.2015.01014. Review.

12.

Investigating psoriasis awareness among patients in Italy: validation of a questionnaire.

Bardazzi F, Amerio P, Amoruso G, Campanati A, Conti A, De Simone C, Gisondi P, Gualdi G, Guarneri C, Loconsole F, Mazzotta A, Musumeci ML, Odorici G, Piaserico S, Potenza C, Scudeller L; Alphard Study Group.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3435-52.

Supplemental Content

Loading ...
Support Center